Fiona H Blackhall

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.

Steven Gray, J. O’Leary, K. O'Byrne, 2012, Lung cancer.

Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity.

Gary Tse, Nathalie Wong, Ming-Sound Tsao, 2003, Lung cancer.

Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

Ashwini Naik, Allan Hackshaw, Zoltan Szallasi, 2017, Nature.

Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.

Caroline Dive, Lee Lancashire, Robert Sloane, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer

Caroline Dive, Andrew Hughes, M. Ranson, 2007, Biomarker insights.

Circulating tumour cells: their utility in cancer management and predicting outcomes

Caroline Dive, T. Ward, C. Dive, 2010, Therapeutic advances in medical oncology.

Tumorigenesis and Neoplastic Progression Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

Caroline Dive, Lee Lancashire, Andrew Hughes, 2010 .

K-ras mutations in non-small-cell lung carcinoma: a review.

Ming-Sound Tsao, M. Tsao, S. Aviel-Ronen, 2006, Clinical lung cancer.

Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.

Caroline Dive, Lee Lancashire, Robert Sloane, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Three-gene prognostic classifier for early-stage non small-cell lung cancer.

Igor Jurisica, Shaf Keshavjee, Paul C Boutros, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.